General Information of Drug Off-Target (DOT) (ID: OTQF5ZAK)

DOT Name Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R)
Synonyms PTH/PTHrP type I receptor; PTH/PTHr receptor; Parathyroid hormone 1 receptor; PTH1 receptor
Gene Name PTH1R
Related Disease
Chondrodysplasia Blomstrand type ( )
Metaphyseal chondrodysplasia, Jansen type ( )
Primary failure of tooth eruption ( )
Eiken syndrome ( )
UniProt ID
PTH1R_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1BL1; 3C4M; 3H3G; 3L2J; 4Z8J; 5EMB; 6NBF; 6NBH; 6NBI; 7UZO; 7UZP; 7VVJ; 7VVK; 7VVL; 7VVM; 7VVN; 7VVO; 7Y35; 7Y36; 8BIA; 8BJ0; 8D51; 8D52; 8FLQ; 8FLR; 8FLS; 8FLT; 8FLU; 8GW8; 8HA0; 8HAF; 8HAO; 8JR9
Pfam ID
PF00002 ; PF02793
Sequence
MGTARIAPGLALLLCCPVLSSAYALVDADDVMTKEEQIFLLHRAQAQCEKRLKEVLQRPA
SIMESDKGWTSASTSGKPRKDKASGKLYPESEEDKEAPTGSRYRGRPCLPEWDHILCWPL
GAPGEVVAVPCPDYIYDFNHKGHAYRRCDRNGSWELVPGHNRTWANYSECVKFLTNETRE
REVFDRLGMIYTVGYSVSLASLTVAVLILAYFRRLHCTRNYIHMHLFLSFMLRAVSIFVK
DAVLYSGATLDEAERLTEEELRAIAQAPPPPATAAAGYAGCRVAVTFFLYFLATNYYWIL
VEGLYLHSLIFMAFFSEKKYLWGFTVFGWGLPAVFVAVWVSVRATLANTGCWDLSSGNKK
WIIQVPILASIVLNFILFINIVRVLATKLRETNAGRCDTRQQYRKLLKSTLVLMPLFGVH
YIVFMATPYTEVSGTLWQVQMHYEMLFNSFQGFFVAIIYCFCNGEVQAEIKKSWSRWTLA
LDFKRKARSGSSSYSYGPMVSHTSVTNVGPRVGLGLPLSPRLLPTATTNGHPQLPGHAKP
GTPALETLETTPPAMAAPKDDGFLNGSCSGLDEEASGPERPPALLQEEWETVM
Function
Receptor for parathyroid hormone and for parathyroid hormone-related peptide. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase and also a phosphatidylinositol-calcium second messenger system.
Tissue Specificity Expressed in most tissues. Most abundant in kidney, bone and liver.
KEGG Pathway
Neuroactive ligand-receptor interaction (hsa04080 )
Parathyroid hormone synthesis, secretion and action (hsa04928 )
Endocrine and other factor-regulated calcium reabsorption (hsa04961 )
Reactome Pathway
G alpha (s) signalling events (R-HSA-418555 )
Class B/2 (Secretin family receptors) (R-HSA-373080 )

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Chondrodysplasia Blomstrand type DISVSUWV Definitive Autosomal recessive [1]
Metaphyseal chondrodysplasia, Jansen type DIS5WUHF Definitive Autosomal dominant [2]
Primary failure of tooth eruption DISL016F Definitive Autosomal dominant [3]
Eiken syndrome DIS4J3C3 Strong Autosomal recessive [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 7 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Doxorubicin DMVP5YE Approved Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) increases the Electrolyte imbalance ADR of Doxorubicin. [12]
Cisplatin DMRHGI9 Approved Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) increases the Electrolyte imbalance ADR of Cisplatin. [12]
Ethanol DMDRQZU Approved Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) increases the Hyperparathyroidism ADR of Ethanol. [12]
Furosemide DMMQ8ZG Approved Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) increases the Hyperparathyroidism ADR of Furosemide. [12]
Urea DMUK75B Approved Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) increases the Renal failure chronic ADR of Urea. [12]
Paricalcitol DMYBV3G Approved Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) increases the Iron and trace metal metabolism disorders ADR of Paricalcitol. [12]
Acetazolamide DM1AF5U Approved Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) increases the Acidosis ADR of Acetazolamide. [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R). [4]
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R). [6]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R). [11]
------------------------------------------------------------------------------------
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Estradiol DMUNTE3 Approved Estradiol increases the expression of Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R). [5]
Calcitriol DM8ZVJ7 Approved Calcitriol decreases the expression of Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R). [7]
Marinol DM70IK5 Approved Marinol decreases the expression of Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R). [8]
Zoledronate DMIXC7G Approved Zoledronate decreases the expression of Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R). [9]
Cytarabine DMZD5QR Approved Cytarabine decreases the expression of Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R). [10]
------------------------------------------------------------------------------------

References

1 Recessive mutations in PTHR1 cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes. Hum Mol Genet. 2005 Jan 1;14(1):1-5. doi: 10.1093/hmg/ddi001. Epub 2004 Nov 3.
2 Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med. 1996 Sep 5;335(10):708-14. doi: 10.1056/NEJM199609053351004.
3 PTHR1 loss-of-function mutations in familial, nonsyndromic primary failure of tooth eruption. Am J Hum Genet. 2008 Dec;83(6):781-6. doi: 10.1016/j.ajhg.2008.11.006.
4 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
5 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
6 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
7 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
8 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
9 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
10 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
11 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
12 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.